Skip to main content

Alpha-satellite RNAs in Epstein-Barr virus lytic replication

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-07-05

About This Grant

SUMMARY Epstein-Barr virus (EBV) is a ubiquitous DNA tumor virus that is causally linked to Hodgkin's and non- Hodgkin's lymphoma, nasopharyngeal carcinoma, stomach cancer, and autoimmune diseases. EBV is particularly problematic in the HIV/AIDS population where EBV-associated lymphomas are especially prevalent. There are two distinct stages in EBV's life cycle: latency and lytic reactivation/replication. The viral lytic replication stage is a key component of the EBV infection cycle that facilitates the spread of the virus not only from host to host but also its dissemination within an infected individual. While EBV latency genes are long known to contribute to the tumor phenotype, EBV lytic replication is a precursor of (through dissemination) and a direct contributor to EBV-associated pathologies including lymphomas and autoimmune diseases. EBV is known to elicit a series of host cellular responses and it can almost always find a way to hijack these host machineries for its own benefits. For instance, EBV infection induces double-stranded breaks (DSBs) and strong DNA damage response (DDR) in host cells. It appears that EBV utilizes a variety of strategies to purposely activate the upstream/early steps of DDR signaling and inactivate the harmful downstream/late steps to ensure cell survival and benefit its own self-preservation. Recently, we have found that EBV lytic replication causes substantial induction of alpha-satellite RNAs (α-SatRNA), a novel host cellular response. This motivates us to further explore its significance in EBV lytic replication. Alpha-satellite DNA (α-SatDNA) is one type of tandem repetitive non-coding (nc) DNA sequences and constitutes 3-5% of the human genome. It also serves as the main building blocks for centromeres and has long been viewed as transcriptionally inert. Surprisingly, these genomic “dark matter” can be actively transcribed by RNA polymerase II to produce non- polyadenylated α-SatRNAs. The unique long repetitive sequence also makes α-SatRNAs a novel class of long ncRNAs. Our preliminary findings show that α-SatRNA levels are substantially induced by EBV lytic replication, accompanied by DNA damage DSBs and ATM activation. We further found that α-SatRNAs are required for efficient EBV lytic replication and α-SatRNAs promote ATM/upstream DDR signaling globally. Based on our published and unpublished findings, we hypothesize that lytic reactivation-induced DSBs on host centromeric α-SatDNA upregulate α-SatRNAs, which subsequently facilitate lytic reactivation by promoting ATM/upstream DDR signaling globally. In this proposal, we will test this hypothesis, we will begin to address the mechanisms through which EBV utilizes α-SatRNAs to facilitate its lytic replication and we will begin to address the mechanisms by which EBV reactivation induces α-SatRNA expression. Together, completion of this work will reveal a novel role of these “understudied” α-SatRNAs and associated underlying mechanisms in EBV lytic replication, and thus add conceptually to our understanding of EBV-host interaction.

Grant Summary

Alpha-satellite RNAs in Epstein-Barr virus lytic replication is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $572K for university, nonprofit, healthcare org. Applications are due 2031-01-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $572K

Deadline

2031-01-31

Complexity
High
  1. 1Confirm your organization is eligible for Alpha-satellite RNAs in Epstein-Barr virus lytic replication from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Alpha-satellite RNAs in Epstein-Barr virus lytic replication: Frequently Asked Questions

Who is eligible for the Alpha-satellite RNAs in Epstein-Barr virus lytic replication?

Alpha-satellite RNAs in Epstein-Barr virus lytic replication is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Alpha-satellite RNAs in Epstein-Barr virus lytic replication provide?

Alpha-satellite RNAs in Epstein-Barr virus lytic replication provides up to $572K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Alpha-satellite RNAs in Epstein-Barr virus lytic replication deadline?

Applications for Alpha-satellite RNAs in Epstein-Barr virus lytic replication are due 2031-01-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Alpha-satellite RNAs in Epstein-Barr virus lytic replication?

To apply for Alpha-satellite RNAs in Epstein-Barr virus lytic replication, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.